These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22146079)

  • 21. Hydrophobic residues Phe552, Phe554, Ile562, Leu566, and Ile574 are required for oligomerization of anthrax protective antigen.
    Ahuja N; Kumar P; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Sep; 287(2):542-9. PubMed ID: 11554763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fusion protein of Delta 27LFn and EFn has the potential as a novel anthrax toxin inhibitor.
    Kong Y; Guo Q; Yu C; Dong D; Zhao J; Cai C; Hou L; Song X; Fu L; Xu J; Chen W
    FEBS Lett; 2009 Apr; 583(8):1257-60. PubMed ID: 19332063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
    Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into the functions of anthrax toxin.
    Banks DJ; Ward SC; Bradley KA
    Expert Rev Mol Med; 2006 Apr; 8(7):1-18. PubMed ID: 16608555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization of peptide-based anthrax toxin inhibitors.
    Gujraty K; Sadacharan S; Frost M; Poon V; Kane RS; Mogridge J
    Mol Pharm; 2005; 2(5):367-72. PubMed ID: 16196489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of a Small Molecule in the Modulation of Cell Death Signal Transduction Pathways.
    Hartmann S; Nusbaum DJ; Kim K; Alameh S; Ho CC; Cruz RL; Levitin A; Bradley KA; Martchenko M
    ACS Infect Dis; 2018 Dec; 4(12):1746-1754. PubMed ID: 30354048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of phage display and polyvalency to design inhibitors of protein-protein interactions.
    Mourez M; Collier RJ
    Methods Mol Biol; 2004; 261():213-28. PubMed ID: 15064461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthrax toxins.
    Mourez M
    Rev Physiol Biochem Pharmacol; 2004; 152():135-64. PubMed ID: 15549606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human antibodies from immunized donors are protective against anthrax toxin in vivo.
    Wild MA; Xin H; Maruyama T; Nolan MJ; Calveley PM; Malone JD; Wallace MR; Bowdish KS
    Nat Biotechnol; 2003 Nov; 21(11):1305-6. PubMed ID: 14555959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between anthrax toxin receptors and protective antigen.
    Scobie HM; Young JA
    Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted silencing of anthrax toxin receptors protects against anthrax toxins.
    Arévalo MT; Navarro A; Arico CD; Li J; Alkhatib O; Chen S; Diaz-Arévalo D; Zeng M
    J Biol Chem; 2014 May; 289(22):15730-8. PubMed ID: 24742682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax.
    Sellman BR; Mourez M; Collier RJ
    Science; 2001 Apr; 292(5517):695-7. PubMed ID: 11326092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells.
    Maldonado-Arocho FJ; Fulcher JA; Lee B; Bradley KA
    Mol Microbiol; 2006 Jul; 61(2):324-37. PubMed ID: 16856939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing a polyvalent inhibitor of anthrax toxin.
    Mourez M; Kane RS; Mogridge J; Metallo S; Deschatelets P; Sellman BR; Whitesides GM; Collier RJ
    Nat Biotechnol; 2001 Oct; 19(10):958-61. PubMed ID: 11581662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
    Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of NF-κB pathway and TNF-α are involved in the cytotoxicity of anthrax lethal toxin in bovine BoMac macrophages.
    Liang X; Gao CF; Rutherford MS; Ji Y
    Vet Microbiol; 2010 Nov; 146(1-2):111-7. PubMed ID: 20537817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of toxin inhibitors using a magnetic nanosensor-based assay.
    Santiesteban OJ; Kaittanis C; Perez JM
    Small; 2014 Mar; 10(6):1202-11. PubMed ID: 24339142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacophore selection and redesign of non-nucleotide inhibitors of anthrax edema factor.
    Schein CH; Chen D; Ma L; Kanalas JJ; Gao J; Jimenez ME; Sower LE; Walter MA; Gilbertson SR; Peterson JW
    Toxins (Basel); 2012 Nov; 4(11):1288-300. PubMed ID: 23202316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening.
    Bannwarth L; Goldberg AB; Chen C; Turk BE
    Chem Biol; 2012 Jul; 19(7):875-82. PubMed ID: 22840775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.